NCT06174454

Brief Summary

The accumulation of secretions in the bronchopulmonary air network promotes the detriment of respiratory functions generating hypoxia and causing a decrease in the cardiac output requiring the use of mechanical ventilation and hemodynamic support. It is intended to control the accumulation of secretions by means of Respiratory Pediatric Physiotherapy (RPP) and to evaluate its effectiveness counting on biological plausibility.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 3, 2018

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

February 18, 2018

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 4, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 4, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 18, 2023

Completed
Last Updated

December 18, 2023

Status Verified

December 1, 2023

Enrollment Period

5.5 years

First QC Date

February 18, 2018

Last Update Submit

December 7, 2023

Conditions

Keywords

PneumoniaRespiratory Pediatric Physiotherapy

Outcome Measures

Primary Outcomes (1)

  • Respiratory difficulty

    The Silverman score will be used with a range of 0 to 10 points, directly proportional between the sum and the respiratory difficulty.

    5 days

Secondary Outcomes (1)

  • Hospital stay

    7 days

Study Arms (2)

Inervention group

EXPERIMENTAL

The intervention group will be subject to RPP. Techniques of slow expiration will be used and slow inspiration for the sweeping of secretions, during its expulsion forced expiratory techniques will be used (tracheal reflex). 10 sessions will be performed, one a day from Monday to Friday, with a duration of 10 to 15 minutes.

Other: Respiratory Pediatric Physiotherapy

Control Group

PLACEBO COMPARATOR

Will be subject to PD plus muscle belly compressions of the upper limbs for 10 sessions, one session a day from Monday to Friday, with a duration de 10 to 15 minutes per patient. Both groups will receive the usual treatment for pneumonia prescribed by their treating doctor.

Other: Control Group

Interventions

Prolonged slow expiration Tracheal pumping Controlled expiratory flow exercises Forced expiration technique

Also known as: Fisioterapia torácica pediatrica
Inervention group

Will be subject to muscle compressions of the upper limbs. Both groups will receive the usual treatment for pneumonia prescribed by their treating doctor.

Control Group

Eligibility Criteria

Age1 Year - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients from the Hospital Infantil de México Federico Góme with diagnosis of pneumonia (considering the diagnostic criteria of the WHO and the Guidelines for Nosocomial Pneumonia from the infectiology department.
  • Patients aged 0 to 8 years old.
  • A minimum HS of 72 hours.
  • Having informed consent.
  • Not having had previous RPP treatment.

You may not qualify if:

  • Presenting a fever state for more than three days. Performing physiotherapy increases the body's peripheral temperature.
  • Presenting an oxygen saturation below 80%.
  • Requiring mechanical ventilation.
  • Hemodynamic instability.
  • Presenting systemic inflammatory response syndrome.
  • Inotropic support.
  • Anatomical variants in the thorax.
  • Unstable thorax.
  • Esophageal atresia.
  • Pleural effusion, pneumothorax.
  • Alterations that compromise respiratory centers and/or the phrenic nerve.
  • Neuromuscular diseases that compromise respiratory mechanics.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Infantil de México Federico Gómez

Mexico City, Delegación Cuauhtémoc, 06720, Mexico

Location

Related Publications (3)

  • Girardi G, et al. El Programa IRA en Chile: hitos e historia. Chil Ped (Chil). 2001; 72: 292-300.

    BACKGROUND
  • European Respiratory Society Annual Congress. Effects of a new chest physiotherapy protocol in infant RSV bronchiolitis; 4-8 october. Berlín: European Respiratory Society; 2008.

    BACKGROUND
  • Postiaux G, Hankard R, Saulnier JP, Karolewicz S, Benielli J, Le Dinahet T, Louis J. Chest physical therapy in infant acute viral bronchiolitis: should we really surrender? Arch Pediatr. 2014 May;21(5):452-3. doi: 10.1016/j.arcped.2014.02.029. Epub 2014 Apr 8. No abstract available.

MeSH Terms

Conditions

Pneumonia

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Adrian Morales, Fisioterapia

    Hospital Infantil de Mexico Federico Gomez

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
1. A sequence of aleatory numbers in blocks of 2 will be generated in each of the study groups using the software randomization.com, done by a person foreign to the research. 2. Using the randomized numbers generated by the software, it will be decided what group each participant belongs to (control or intervention) and what maneuver will be assigned to them. 3. These numbers and their maneuvers will be placed inside dark envelopes. 4. The whole randomization and assignment sequence will be performed by a person foreign to the research and without the knowledge of the researchers. Support will be provided from the coordination for nursing research, who will select the personnel for the process.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The population will consist of children aged from 0 to 8 years old diagnosed with pneumonia with a development time less than 7 days. he sample calculation corresponds to 40 participants per group. The intervention group will be exposed to techniques such as prolonged slow expiration, controlled expiratory flow exercises, tracheal pumping and tracheal reflex. The control group will be subject to postural drainage plus compressions to the muscle belly of the upper limbs. Both groups will go through 10 sessions: One daily session from Monday to Friday with a duration of 10 to 15 minutes each
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 18, 2018

First Posted

December 18, 2023

Study Start

February 3, 2018

Primary Completion

August 4, 2023

Study Completion

November 4, 2023

Last Updated

December 18, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations